Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis
- 19 August 2015
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 122 (10), 1976-1986
- https://doi.org/10.1016/j.ophtha.2015.06.043
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Associations among Visual Acuity and Vision- and Health-Related Quality of Life among Patients in the Multicenter Uveitis Steroid Treatment TrialInvestigative Opthalmology & Visual Science, 2012
- Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment TrialOphthalmology, 2011
- The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline CharacteristicsAmerican Journal of Ophthalmology, 2010
- Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the EvidenceAmerican Journal of Ophthalmology, 2008
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsNew England Journal of Medicine, 2007
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994
- Criterion validity and reliability of the SF-36 in a population sampleQuality of Life Research, 1994
- Validating the SF-36 health survey questionnaire: new outcome measure for primary care.BMJ, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990